Ahmad Alikhani
Overview
Explore the profile of Ahmad Alikhani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alikhani A, Ahmadi N, Frouzanian M, Abdollahi A
BMC Infect Dis
. 2024 May;
24(1):491.
PMID: 38745172
Brucellosis, a zoonotic disease caused by Brucella species, poses a significant global health concern. Among its diverse clinical manifestations, neurobrucellosis remains an infrequent yet debilitating complication. Here, we present a...
2.
Samaee H, Eslami G, Rahimzadeh G, Saeedi M, Davoudi Badabi A, Asare-Addo K, et al.
J Drug Deliv Sci Technol
. 2023 May;
84:104486.
PMID: 37123173
Inhalation phage therapy is proposed as a replacement approach for antibiotics in the treatment of pulmonary bacterial infections. This study investigates phage therapy on bacterial pneumonia in patients with moderate...
3.
Alikhani A, Abbaspour Kasgari H, Majidi H, Nekoukar Z
Clin Case Rep
. 2022 Oct;
10(9):e6366.
PMID: 36188036
Brucella is a rare pathogen of the lung. This intracellular organism can involve pleura in the sub-acute and chronic course of the disease. Here, we introduce an infrequent case of...
4.
Alikhani A, Mahmoodi K, Delavaryan L, Salehifar E, Rafiei A, Sadeghi Zavare M
Caspian J Intern Med
. 2022 Aug;
13(2):343-348.
PMID: 35919644
Background: The northern coastal regions of Iran are endemic for leptospirosis which may range from a subclinical illness to a progressively fatal disease. There has been growing evidence that inflammatory...
5.
Alikhani A, Ghazaiean M, Ghasemian R, Khademloo M
Caspian J Intern Med
. 2022 Jul;
13(Suppl 3):173-179.
PMID: 35872684
Background: Evaluation of protease inhibitors (PIs) is important in terms of prescribing an effective regimen for reducing mortality and hospitalization in Covid-19. Therefore, follow-up of patients better determines the characteristics...
6.
Rezai M, Ahangarkani F, Hill A, Ellis L, Mirchandani M, Davoudi A, et al.
Front Med (Lausanne)
. 2022 Jul;
9:919708.
PMID: 35783616
Background: Ivermectin which was widely considered as a potential treatment for COVID-19, showed uncertain clinical benefit in many clinical trials. Performing large-scale clinical trials to evaluate the effectiveness of this...
7.
Nekoukar Z, Ala S, Moradi S, Hill A, Davoudi Badabi A, Alikhani A, et al.
Iran J Pharm Res
. 2022 Feb;
20(4):278-288.
PMID: 35194446
This was a randomized, double-blind clinical trial to compare the efficacy and safety of Atazanavir/Ritonavir (ATZ/RTV) with Lopinavir/Ritonavir (LPV/RTV) in moderate Coronavirus disease 2019 (COVID-19). Participants were randomly assigned to...
8.
Shokri-Afra H, Alikhani A, Moradipoodeh B, Noorbakhsh F, Fakheri H, Moradi-Sardareh H
Sci Rep
. 2021 Nov;
11(1):22001.
PMID: 34753964
Intestinal epithelial cell damage caused by SARS-CoV-2 infection was thought to be associated with gastrointestinal symptoms and decreased fecal consistency. The association of the gastrointestinal symptoms with the COVID-19-mediated inflammatory...
9.
Babamahmoodi F, Saeedi M, Alizadeh-Navaei R, Hedayatizadeh-Omran A, Mousavi S, Ovaise G, et al.
Sci Rep
. 2021 Nov;
11(1):21464.
PMID: 34728696
The Sputnik V is a COVID- 19 vaccine developed by the Gamalia institute of epidemiology and microbiology and released on August 11, 2020. We provided independent evidence on side effects...
10.
Abbaspour Kasgari H, Moradi S, Shabani A, Babamahmoodi F, Davoudi Badabi A, Davoudi L, et al.
J Antimicrob Chemother
. 2020 Aug;
75(11):3373-3378.
PMID: 32812025
Background: New therapeutic options are urgently needed to tackle the novel coronavirus disease 2019 (COVID-19). Repurposing existing pharmaceuticals provides an immediate treatment opportunity. We assessed the efficacy of sofosbuvir and...